Related Experiment Video

Updated: Apr 28, 2026

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring
08:45

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring

Published on: November 17, 2018

13.2K

Reducing elevated plasma LDL cholesterol: the central role of the LDL receptor

J Vincent1

  • 1Pfizer Global Pharmaceuticals, New York, New York, USA.

Clinical Pharmacology and Therapeutics
|June 20, 2014
PubMed

Insights

High low-density lipoprotein cholesterol (LDL-C) increases cardiovascular disease (CVD) risk. Reducing LDL-C, particularly through LDLR-targeting drugs, lowers mortality in at-risk patients.

Area of Science:

  • Cardiovascular Medicine
  • Molecular Genetics
  • Pharmacology

Background:

  • Elevated low-density lipoprotein cholesterol (LDL-C) is a significant risk factor for cardiovascular disease (CVD).
  • The LDL receptor (LDLR) pathway is crucial for managing LDL-C levels and has been a focus for therapeutic interventions.
  • Statins have demonstrated the benefit of LDL-C reduction in mitigating CVD mortality.

Discussion:

  • The efficacy of current dyslipidemia treatments is largely attributed to their interaction with the LDLR.
  • Understanding the intricate regulation of the LDLR has opened avenues for novel therapeutic strategies.
  • Molecular genetics advancements are key to identifying and validating new pharmacological targets.

Key Insights:

  • Targeting the LDLR pathway is a validated strategy for reducing cardiovascular risk.
  • Novel drug development is exploring mechanisms beyond traditional statins to modulate LDLR function.
  • Personalized medicine approaches may emerge from a deeper understanding of LDLR regulation.

Outlook:

  • Future therapies aim for more precise modulation of lipid metabolism through LDLR-related targets.
  • Continued research in molecular genetics will uncover new targets for treating dyslipidemias.
  • The development of targeted therapies promises improved outcomes for patients with high LDL-C and CVD risk.

More Related Videos

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

14.8K
Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein07:29

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein

Published on: October 12, 2017

8.4K

Related Concept Videos

Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
2.0K
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.7K
Receptor-mediated Endocytosis01:38

Receptor-mediated Endocytosis

Overview
105.3K
Receptor-mediated Endocytosis01:20

Receptor-mediated Endocytosis

Receptor-mediated endocytosis is when bulk amounts of specific molecules are imported into a cell after binding to cell surface receptors. The molecules bound to these receptors are taken into the cell through inward folding of the cell surface membrane, which is eventually pinched off into a vesicle within the cell. Structural proteins, such as clathrin, coat the budding vesicle.
Clathrin-Mediated Endocytosis of LDL
One well-characterized example of receptor-mediated endocytosis is the...
10.2K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
723
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
888